Cargando…

Comparative study of corticosteroid monotherapy, and TNF inhibitors with or without corticosteroid in patients with refractory entero-Behcet’s disease

BACKGROUND: Tumor necrosis factor (TNF) inhibitors (TNF-i) are effective in the treatment of entero-Behcet’s disease (BD). However, there is no objective tool for assessment of disease activity in entero-BD; therefore, it is not easy to evaluate treatment effectiveness in the clinical setting. In ad...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyagawa, Ippei, Nakano, Kazuhisa, Iwata, Shigeru, Nakayamada, Shingo, Saito, Kazuyoshi, Hanami, Kentaro, Fukuyo, Shunsuke, Kubo, Satoshi, Kawabe, Akio, Miyazaki, Yusuke, Tanaka, Yoshiya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589167/ https://www.ncbi.nlm.nih.gov/pubmed/31228955 http://dx.doi.org/10.1186/s13075-019-1933-8

Ejemplares similares

Effectiveness and safety of mepolizumab in combination with corticosteroids in patients with eosinophilic granulomatosis with polyangiitis
por: Ueno, Masanobu, et al.
Publicado: (2021)

Serum TNFα levels at 24 h after certolizumab pegol predict effectiveness at week 12 in patients with rheumatoid arthritis from TSUBAME study
por: Miyazaki, Yusuke, et al.
Publicado: (2021)

IgG4-related Pleuritis with Elevated Adenosine Deaminase in Pleural Effusion
por: Nagayasu, Atsushi, et al.
Publicado: (2018)

Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes
por: Ueno, Masanobu, et al.
Publicado: (2022)

Correction: Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes
por: Ueno, Masanobu, et al.
Publicado: (2023)

Safety and effectiveness of mepolizumab therapy in remission induction therapy for eosinophilic granulomatosis with polyangiitis: a retrospective study
por: Ueno, Masanobu, et al.
Publicado: (2022)

Efficacy and safety of belimumab during maintenance therapy in patients with systemic lupus erythematosus
por: Miyazaki, Yusuke, et al.
Publicado: (2021)

Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study
por: Tanaka, Yoshiya, et al.
Publicado: (2015)

Eosinophilic granulomatosis with polyangiitis exhibits T cell activation and IgG4 immune response in the tissue; comparison with IgG4-related disease
por: Kubo, Satoshi, et al.
Publicado: (2022)

An Autopsy Case with Cerebral Hemorrhaging due to disseminated Aspergillosis During Glucocorticoid Therapy for Overlap Syndrome of Systemic Lupus Erythematosus and Systemic Sclerosis
por: Ueno, Masanobu, et al.
Publicado: (2018)

Th22 Cells Promote Osteoclast Differentiation via Production of IL-22 in Rheumatoid Arthritis
por: Miyazaki, Yusuke, et al.
Publicado: (2018)

Favorable efficacy of rituximab in ANCA-associated vasculitis patients with excessive B cell differentiation
por: Miyazaki, Yusuke, et al.
Publicado: (2020)

Impact of serum interleukin-22 as a biomarker for the differential use of molecular targeted drugs in psoriatic arthritis: a retrospective study
por: Miyagawa, Ippei, et al.
Publicado: (2022)

Generation-Dependent Retention Rates and Reasons for Discontinuation of Molecular Targeted Therapies in Patients with Rheumatoid Arthritis: From FIRST Registry
por: Kubo, Satoshi, et al.
Publicado: (2023)

Precision medicine based on the phenotypic differences in peripheral T helper cells in patients with psoriatic arthritis: One year follow-up outcomes
por: Miyagawa, Ippei, et al.
Publicado: (2022)

Remission of Granulomatosis with Polyangiitis Only After Resection of a Pulmonary Nodule
por: Kanda, Ryuichiro, et al.
Publicado: (2022)

Comparative outcomes of combined corticosteroid and remdesivir therapy with corticosteroid monotherapy in ventilated COVID-19 patients
por: Mandadi, Subhadra, et al.
Publicado: (2022)

Discontinuation of adalimumab after attaining disease activity score 28-erythrocyte sedimentation rate remission in patients with rheumatoid arthritis (HONOR study): an observational study
por: Hirata, Shintaro, et al.
Publicado: (2013)

Chlorhexidine Monotherapy with Adjunctive Topical Corticosteroids for Acanthamoeba Keratitis
por: Rahimi, Firoozeh, et al.
Publicado: (2015)

Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus
por: Sakata, Kei, et al.
Publicado: (2018)

Efficacy and safety of tofacitinib versus baricitinib in patients with rheumatoid arthritis in real clinical practice: analyses with propensity score-based inverse probability of treatment weighting
por: Miyazaki, Yusuke, et al.
Publicado: (2021)

Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis
por: Ishikawa, Yuichi, et al.
Publicado: (2018)

Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy
por: Min, Lulin, et al.
Publicado: (2017)

Role of DNA dioxygenase Ten-Eleven translocation 3 (TET3) in rheumatoid arthritis progression
por: Kawabe, Akio, et al.
Publicado: (2022)

Interrelated modulation of endothelial function in Behcet's disease by clinical activity and corticosteroid treatment
por: Protogerou, Athanase D, et al.
Publicado: (2007)

Outcome in patients with idiopathic retroperitoneal fibrosis treated with corticosteroid or tamoxifen monotherapy
por: van der Bilt, Floor E., et al.
Publicado: (2016)

Short-term Outcomes of Corticosteroid Monotherapy in Multisystem Inflammatory Syndrome in Children
por: Villacis-Nunez, D. Sofia, et al.
Publicado: (2022)

Addition of Montelukast to Low-Dose Inhaled Corticosteroid Leads to Fewer Exacerbations in Older Patients Than Medium-Dose Inhaled Corticosteroid Monotherapy
por: Ye, Young-Min, et al.
Publicado: (2015)

Corticosteroids
por: Caramori, Gaetano, et al.
Publicado: (2019)

Combination therapy of infliximab and thalidomide for refractory entero-Behcet's disease: a case report
por: Li, Yue, et al.
Publicado: (2013)

Recurrent Interstitial Pneumonitis in a Patient with Entero-Behçet's Disease Initially Treated with Mesalazine
por: Nakamura, Akihiro, et al.
Publicado: (2016)

Parallel disease activity of Behçet’s disease with renal and entero involvements: a case report
por: Watanabe-Kusunoki, Kanako, et al.
Publicado: (2021)

Effects of corticosteroid and chlorambucil on multiple pulmonary artery aneurysms in Behcet's syndrome. A case report.
por: Park, J. Y., et al.
Publicado: (1995)

Differential long-term retention of biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis by age group from the FIRST registry
por: Kawabe, Akio, et al.
Publicado: (2020)

Dexamethasone may be the most efficacious corticosteroid for use as monotherapy in castration-resistant prostate cancer
por: Holder, S L, et al.
Publicado: (2015)

Half-fluence Photodynamic Therapy for Central Serous Chorioretinopathy in a Patient Receiving Corticosteroids for Behçet’s Uveitis
por: Özdemir, Hüseyin Baran, et al.
Publicado: (2022)

Acute Fibrinous and Organizing Pneumonia with Myelodysplastic Syndrome: Corticosteroid Monotherapy Led to Successful Ventilator Weaning
por: Yamamoto, Mari, et al.
Publicado: (2016)

Inhaled Corticosteroids
por: Barnes, Peter J.
Publicado: (2010)

Topical Corticosteroids
por: Greaves, M. W., et al.
Publicado: (1987)

Corticosteroids in ARDS
por: Kuperminc, Emmanuelle, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bv05she7m2grdojmict3tigsmm